Indication

Thromboembolism due to prosthetic heart valves

Thromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation. Read more about Thromboembolism due to prosthetic heart valves

32 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Thromboembolism due to prosthetic heart valves therapies.

Showing 19–27 of 32 drugs

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
A-S MEDICATION

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
GSMS, INC.

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
ST MARYS MPP

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
DIRECT RX

DIPYRIDAMOLE

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·THROMBOEMBOLISM DUE TO PROSTHETIC HEART VALVES
PROFICIENT RX L

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
PROFICIENT RX L

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
BRYANT RANCH PR

DIPYRIDAMOLE

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·THROMBOEMBOLISM DUE TO PROSTHETIC HEART VALVES
OXFORD PHARMACE

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
APHENA PHARMA S
Filter & compare in the drug finder →Opens the drug finder with Thromboembolism due to prosthetic heart valves preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Thromboembolism due to prosthetic heart valves.

Thromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation.

This condition primarily affects patients with mechanical or bioprosthetic valve replacements, driven by altered hemodynamics, foreign material thrombogenicity, endothelial disruption, and shear stress–induced platelet activation and coagulation cascade triggering.

Clinically, it manifests either as local valve thrombosis leading to valvular obstruction and acute heart failure, or as distal embolic phenomena causing ischemic stroke, transient ischemic attack, or systemic organ infarction.

Personalize your experience

Follow Thromboembolism due to prosthetic heart valves and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it